Skip to main content
    T

    Tenax Therapeutics Inc (TENX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.48
    -0.14 (-8.64%)

    Market Cap: $73.77M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Tenax Therapeutics Inc (TENX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Tenax Therapeutics are Tenaya Therapeutics (TNYA), Tonix Pharmaceuticals Holding (TNXP) and NRX Pharmaceuticals (NRXP). By market cap, Tenax Therapeutics ranks 7th of the 13 companies on this page; LENZ Therapeutics (LENZ) is the largest at $129.77M.

    Peer Comparison

    TENX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Tenax Therapeutics (TENX)$73.77MN/AN/A0.0%N/A0.0%0.00%
    Tenaya Therapeutics Inc (TNYA)$79.59MN/AN/A0.0%N/A0.0%0.00%
    Tonix Pharmaceuticals Holding Corp (TNXP)$58.49MN/A1.2x0.0%N/A423.8%0.00%
    NRX Pharmaceuticals Inc (NRXP)$95.58MN/A23.8x0.0%N/A0.0%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    Gain Therapeutics Inc (GANX)$46.31MN/AN/A0.0%-170.5%-100.0%0.00%
    vTv Therapeutics Inc (VTVT)$78.99MN/AN/A-20.8%N/A0.0%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Actinium Pharmaceuticals Inc (ATNM)$51.56M4.1x1.3x32.2%N/A-100.0%0.00%
    Anixa Biosciences Inc (ANIX)$91.08MN/AN/A0.0%N/A0.0%0.00%
    Rein Therapeutics Inc (RNTX)$47.63MN/AN/A0.0%N/A0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    LENZ Therapeutics Inc (LENZ)$129.77MN/A9.7x0.0%N/A-72.9%0.00%
    Peer median$68.74M4.1x2.0x0.0%-260.5%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Tenax Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Tenaya Therapeutics Inc (TNYA)
    Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary...
    TNYA competitors
    Tonix Pharmaceuticals Holding Corp (TNXP)
    Tonix Pharmaceuticals Holding Corp. The company is headquartered in Chatham, New Jersey.
    TNXP competitors
    NRX Pharmaceuticals Inc (NRXP)
    NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company...
    NRXP competitors
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors
    Gain Therapeutics Inc (GANX)
    Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding.
    GANX competitors
    vTv Therapeutics Inc (VTVT)
    vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet...
    VTVT competitors
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors
    Actinium Pharmaceuticals Inc (ATNM)
    Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation...
    ATNM competitors
    Anixa Biosciences Inc (ANIX)
    Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
    ANIX competitors
    Rein Therapeutics Inc (RNTX)
    Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders...
    RNTX competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    LENZ Therapeutics Inc (LENZ)
    LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders...
    LENZ competitors

    Frequently Asked Questions About TENX

    Who are Tenax Therapeutics' main competitors?

    The companies most similar to Tenax Therapeutics include Tenaya Therapeutics (TNYA), Tonix Pharmaceuticals Holding (TNXP), NRX Pharmaceuticals (NRXP), Neumora Therapeutics (NMRA) and Gain Therapeutics (GANX), listed from the closest match.

    Who is Tenax Therapeutics' biggest competitor?

    LENZ Therapeutics (LENZ) is the largest of the similar companies at $129.77M; Tenaya Therapeutics (TNYA) is the closest match by business profile, size, sector and industry.

    How does TENX stock compare with its competitors?

    TENX's net margin is 0.0% against a peer median of 0.0%.

    Which of Tenax Therapeutics' competitors pays a higher dividend?

    Tenax Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Tenax Therapeutics bigger than its competitors?

    No. Tenax Therapeutics is 7th by market cap among the 13 companies on this page; the largest is LENZ Therapeutics (LENZ) at $129.77M.